LAROSA JOSEPH J (SVP General Counsel and Secret) exercised options at REGENERON PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/21/2026ACC: 0001238303-26-000002
Officer· SVP General Counsel and Secret
Since Dec 2018
-9.02K
Net shares
Net seller
$7.49M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
12.28K acquired · 21.30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.28K
Price / share
$381.92
Trade value
$4.69M
% of position
37.1%
8/19/2026
33.11K→45.39K
Common Stock
Direct
Shares
−9.02K
Price / share
$830.15
Trade value
$7.49M
% of position
19.9%
8/19/2026
45.39K→36.37K
Total
Net shares
+3.26K
Net value
-$2.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2026 | M · Option Exercise | +12.28K | $381.92 | $4.69M | 37.1% | 33.11K | 45.39K |
| Common Stock Direct | 8/19/2026 | F · Tax Withholding | −9.02K | $830.15 | $7.49M | 19.9% | 45.39K | 36.37K |
| Total | +3.26K | -$2.80M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
12.28K shares
Shares
−12.28K
Strike price
381.92
Held after
12.28K
Exercisable
—
8/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock12.28K shares | 8/19/2026 | M · Option Exercise | −12.28K | 381.92 | — | 12.28K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned413.00
Common Stock
IndirectShares owned5.41K
Common Stock
IndirectShares owned3.40K
Total
9.22K indirect9.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 413.00 | Indirect |
| Common Stock | 5.41K | Indirect |
| Common Stock | 3.40K | Indirect |
| Total | 9.22K | 9.22K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported